SPMI-HIF2-1

N/A

Report date: 2023/03/07 15:53:37
NME

Base Information

Drug NameSPMI-HIF2-1
Drug Alias NameSPMI-HIF2-1
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionProtein Mdm4 degradersp53-binding protein Mdm-2 degraders
TargetsProtein Mdm4p53-binding protein Mdm-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai University
China Registration ClassN/A

Develop Information

Active CompaniesShanghai University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A